Pyloriset (Orion Diagnostica, Espoo, Finland) is a rapid antibody test using latex particles coated with acid-extracted antigen of Helicobacter pylori. We evaluated its ability to predict infection in 100 adult patients and 50 pediatric patients referred for gastric endoscopy. Sixty of 65 H. pylori-infected adults were correctly identified by the test. There were 12 false-positive and 5 false-negative reactions seen. Pyloriset had a sensitivity of 92% and a specificity of 66%. The positive predictive value was 83% and the negative predictive value 82%. In contrast, sensitivity dropped to 36% in the pediatric patients and the positive predictive value was only 40%. Pyloriset could become an important alternative to other more time-consuming diagnostic tests for H.
pylori-infected adult patients but is inadequate for diagnosis of pediatric H. pylori infection.
Culture (3) , histological examination (6) , and rapid urease tests (12) are established means of diagnosing Helicobacter pylori. They are highly accurate but have the drawback of requiring gastroduodenoscopy. Current noninvasive procedures for diagnosis include serology (2, 9) and urea breath (7) testing. Serology tests can have high sensitivity and specificity but have the disadvantage of needing a laboratory set up to be performed. Turnaround time for results can become long when the test has to be sent out to another institution. The urea breath test calls for equipment that may not be readily available at all institutions and uses radioactive material. A latex agglutination test for antibodies to H. pyloni combines the advantages of a noninvasive test with speed and low cost.
Pyloriset (Orion Diagnostica, Espoo, Finland) is a latex agglutination test for rapid diagnosis of H. pylori antibodies in serum. The test uses latex particles coated with acidextracted antigen of H. pylori. In a pilot study by the manufacturer, Pyloriset had a sensitivity of 97% and a specificity of 95% by using enzyme immunoassay as the "gold standard" (5) . We now have evaluated Pyloriset in adult and pediatric patients in the United States.
MATERIALS AND METHODS
The first patient sample consisted of 100 adult patients who had undergone gastroduodenoscopy for dyspeptic symptoms. Their ages ranged from 26 to 93 years, with a mean age of 57.4 years. All the patients were males. At the time of endoscopy, we collected biopsies for culture and histology tests and blood for enzyme-linked immunosorbent assay (ELISA). The second group consisted of 50 pediatric patients referred for gastroduodenoscopy because of symptoms consistent with acid peptic disease, such as chronic abdominal pain, vomiting, or hematemesis. Their ages ranged from 4 current data suggest that there is also a difference in humoral response. There could be several explanations for such a difference. It is our experience that the mean titers among infected pediatric patients usually are lower than the mean titers in infected adult patients. The mean optical density (+ standard deviation) for our positive pediatric serum samples was 0.62 (± 0.28) compared with 0.97 (+ 0.30) for the positive adult serum samples. This difference was highly significant (P = 0.002) and could explain some of the decreased sensitivity. There also could be a difference in the quality of antibody response between adults and children. We know that this is true for some infections such as Haemophilus influenzae, for which only children older than 6 years consistently show the same antibody response as adults (11) . Our patients were older than that, but very little is known about H. pylori antigen recognition in different age groups. We have found considerable individual variation in antibody response to one of the three major outer membrane proteins of H. pylori (1) . By Western blot (immunoblot) analysis, almost half of the serum samples from infected pediatric patients lacked antibody to a 32-kDa protein and only 1 of 15 recognized a fourth 14-kDa protein. We have also found a difference in antibody class response between adults and children. In contrast to adults, infected children fail to uniformly mount a significant systemic immune response by serologic immunoglobulin A (2). Since Pyloriset measures total antibody, such differences also could theoretically affect sensitivity.
We conclude that Pyloriset could become an important alternative to other more time-consuming diagnostic tests for H. pylori infection in adult patients. In contrast, we find that the test is inadequate for diagnosing H. pylori infection in pediatric patients. A modified test, possibly using different antigens or a different serum dilution, might be needed for the pediatric patient population.
